(688221)"Frontier Biotechnologies Inc."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688221 · · 2 pages · Chinese
Frontier Biotechnologies Inc. on 6ix
Story so far
Earlier from Frontier Biotechnologies
- Indicative Announcement on Change in Equity Interests of Shareholder Holding More Than 5% of the Shares Reaching 1% and 5% Thresholds
- Announcement on Return of Idle Raised Funds Temporarily Used to Supplement Working Capital
- Announcement on Use of Temporarily Idle Raised Funds for Cash Management
- Voluntary Disclosure Announcement on Obtaining Drug Registration Certificate for FB3002 Loxoprofen Sodium Patches
- Indicative Announcement on Change in Equity of Shareholders Holding More Than 5% of the Shares Reaching 1% and 5% Threshold
Later from Frontier Biotechnologies
- (688221)"Frontier Biotechnologies Inc."Announcement on Notifying Creditors of Using Reserve Funds to Make Up for Losses
- (688221)"Frontier Biotechnologies Inc."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Frontier Biotechnologies into a list and get an email when it puts out news.
Follow Frontier Biotechnologies